Blog
OTHERS

Molecules in the palm of your hand: how VR accelerates drug discovery and prepares the pharmacists of the future

2026-05-29 18:54
Developing a new drug is like searching for the key to a very complex lock. The "lock" is a target protein in our body, and the "key" is the molecule of the future drug. Mistakes are costly: billions of dollars and years of work can be wasted if it turns out late in the process that the key doesn't fit.
For years, scientists tried to solve this puzzle by staring at a flat screen. But the process of a molecule binding to a protein happens in four dimensions: three spatial dimensions plus time, as molecules are constantly moving and changing shape. How can you intuitively understand this complex 4D problem by looking at a 2D image? Before — no way. Today — with the help of virtual reality.
"Virtual reality is a tool capable of bringing transformational changes in areas such as visualizing complex 3D data, which is particularly important for structure-based drug design (SBDD)."
But let's turn to the facts that prove VR is not the future, but the present of pharmaceuticals.

Assembly speed: a problem solved in minutes instead of years

One of the most famous studies in this field was conducted by the University of Bristol. Scientists set up an experiment: could ordinary people, with no special education, "assemble" a drug inside a viral protein using VR headsets and interactive molecular simulations? They were tasked with finding an inhibitor molecule for the neuraminidase of the influenza virus — the one that fits perfectly into the protein's active center and blocks it.
The result surprised even the researchers themselves. Participants, who had never done docking before, were able to correctly determine the position of the drug inside the protein simply by manipulating the molecule in virtual space. Most importantly, they did it in just 5 minutes of real time. Their "intuitive assembly" matched data that scientists had spent years obtaining through painstaking laboratory work.
Here, VR acted not just as a fancy visualizer. It engaged human spatial thinking and natural motor skills, turning abstract modeling into a literally tangible process. In essence, the researchers confirmed Licklider's hypothesis of "man-computer symbiosis," where humans take on spatial thinking and intuition, and machines take on accuracy and calculation speed.
Source: PLOS One, 2020 (University of Bristol)

Step by step: how VR trains pharmacists and scientists

Before creating new drugs, we need to raise a new generation of researchers capable of thinking in three dimensions. And here, VR is already showing impressive results.
Example from Germany: Furtwangen University (HFU) has implemented VR scenarios for studying chemistry and drug development. Students in VR headsets can "climb inside" anticancer drugs like imatinib and examine their effect on target proteins literally at the atomic level. The result? VR lectures became 4 times more popular than regular ones.
Source: HFU news, 2024 (Germany)
Example from Austria: The Medical University of Graz also uses the Nanome platform to train students. Here, future doctors and pharmacists work in small groups on real cases (for example, studying the molecular cause of carcinoma development). Students can not just "look" at a mutated protein but literally enter its structure, see where the breakdown occurred, and work together to find a solution. This interactive experience (peer learning) improves the quality of learning, as each participant can "follow" their colleague's explanations within the VR environment.
*Source: Arxiv, 2025 (Zurich University of Applied Sciences / University of Bristol)*

Scientist community: collaborative work in a virtual lab

Drug development is always teamwork, where chemists, biologists, and pharmacologists must see the same molecule and understand each other at a glance. VR allows them to gather in one virtual room, even from different countries. They can simultaneously interact with a single 3D model, use gestures to point out specific areas, rotate the molecule, and make changes on the fly. Giants like the biotech company Roivant Sciences have already deployed major VR platforms, bringing together dozens of scientists across America to accelerate the drug discovery process.
This isn't just a video conference. It's a shared "experience" of space that creates a sense of real presence and allows for faster consensus.

What does this mean for the pharmaceutical industry?

The numbers speak for themselves:
  • 2–10x acceleration: O'Connor's research showed that for tasks requiring complex 3D manipulations, VR provides a speedup of 2 to 10 times compared to a mouse and keyboard.
  • Lowering barriers: VR allows even untrained people to solve complex molecular problems that were previously only accessible to niche experts.
  • Increased engagement: Educational programs using VR demonstrate 4 times higher interest and better retention of knowledge.

How does VR Concept help build this foundation?

  • Chemistry and Biology: Our VR lessons for schools and colleges allow students to "rotate" 3D models of molecules, assemble atoms, and see chemical reactions from the inside, building proper 3D thinking from the very first courses.
  • Medicine: In collaboration with leading medical universities, we help future pharmacists and doctors study anatomy and pharmacology in 3D volume, without expensive drugs or anatomical material.
  • No-Code Platform: Our main tool is the ability for teachers and methodologists to independently create immersive lessons and simulations without writing code.
Want to implement VR in your pharmaceutical lab or educational center?
Share your challenge. We'll show you how VR Concept can become the foundation for your educational or scientific project.